Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Projects will be assessed on: strength of rationale; quality of science; un-met medical need; future commercial opportunity and clinical implementation into LMIC settings; IP position; likelihood of developing a full proposal to be submitted to external translational award schemes, or similar follow-on funding schemes, within the required timescale and budget.  Should ethics and/or home office approvals be required for the projects, priority will be given to those applications that already have these in place.

Applications will be reviewed by the MORU-Oxford DiTi Panel in mid-October and a funding decision will be made. Award letters will be sent out by 31st October.

Please note, the MORU-Oxford DiTi Panel membership comprises both internal academic and external commercial experts to ensure robust, vigorous review in line with funder recommendations. All external members are required to sign a CDA prior to reviewing applications. Find further further information on Panel membership.